Kizoo portfolio company Underdog closes USD10m financing round
Underdog Pharmaceuticals, a key investment of Michael Greve’s rejuvenation biotech VC Kizoo, has closed a USD10 million round of capital. Kizoo led the company’s Series Seed II round, which saw participation from both existing and new investors. Accounting for up to 40 per cent of deaths in Europe and the